Aura Biosciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MATRIX CAPITAL MANAGEMENT COMPANY, LP | 02/13/2025 | 6.92 M | $56.91 M | 0.00% | 13.94% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 4.88 M | $40.12 M | 0.00% | 9.83% |
EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 4.08 M | $33.54 M | -29.68% | 8.22% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.55 M | $29.19 M | 12.37% | 7.15% |
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | 01/23/2025 | 3.04 M | $24.99 M | 0.00% | 6.12% |
LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 2.54 M | $20.86 M | 123.88% | 5.11% |
VANGUARD GROUP INC | 02/11/2025 | 1.92 M | $15.76 M | 6.22% | 3.86% |
FRANKLIN RESOURCES INC | 02/12/2025 | 1.72 M | $14.16 M | 3.24% | 3.47% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.27 M | $10.44 M | 0.00% | 2.56% |
LEVIN CAPITAL STRATEGIES, L.P. | 02/05/2025 | 1.25 M | $10.26 M | 201.62% | 2.51% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.01 M | $8.33 M | 0.39% | 2.04% |
STATE STREET CORP | 02/14/2025 | 801,823 | $6.59 M | 6.23% | 1.61% |
UBS GROUP AG | 02/14/2025 | 687,322 | $5.65 M | 3,026.18% | 1.38% |
REGENCY CAPITAL MANAGEMENT INC.\DE | 01/21/2025 | 609,424 | $5.01 M | -8.67% | 1.23% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 556,941 | $4.58 M | 7.91% | 1.12% |
DECHENG CAPITAL LLC | 02/14/2025 | 515,555 | $4.24 M | 0.00% | 1.04% |
02/14/2025 | 472,576 | $3.88 M | 100.00% | 0.95% | |
ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 390,695 | $3.21 M | 43.27% | 0.79% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 365,824 | $3.01 M | 24.96% | 0.74% |
PLATINUM INVESTMENT MANAGEMENT LTD | 02/11/2025 | 162,358 | $1.33 M | 0.00% | 0.33% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 154,054 | $1.27 M | 35.17% | 0.31% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 138,466 | $1.14 M | 0.08% | 0.28% |
UBS OCONNOR LLC | 02/14/2025 | 136,516 | $1.12 M | 27.71% | 0.27% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 131,054 | $1.08 M | 12.60% | 0.26% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 106,270 | $873,538 | 0.32% | 0.21% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 95,706 | $786,704 | 0.00% | 0.19% |
JPMORGAN CHASE & CO | 02/12/2025 | 94,386 | $775,853 | 76.42% | 0.19% |
AMERIPRISE FINANCIAL INC | 02/14/2025 | 85,586 | $703,518 | -2.29% | 0.17% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 83,700 | $688,014 | 489.44% | 0.17% |
RHUMBLINE ADVISERS | 01/30/2025 | 73,619 | $605,140 | -0.36% | 0.15% |
BARCLAYS PLC | 02/13/2025 | 72,725 | $598,000 | 19.20% | 0.15% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 69,030 | $567,427 | 14.99% | 0.14% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 63,076 | $518,485 | -1.22% | 0.13% |
TBH GLOBAL ASSET MANAGEMENT, LLC | 02/03/2025 | 60,322 | $495,850 | 0.00% | 0.12% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 47,701 | $392,102 | 33.92% | 0.10% |
DEUTSCHE BANK AG\ | 02/14/2025 | 44,085 | $362,379 | 56.70% | 0.09% |
ALPS ADVISORS INC | 02/13/2025 | 40,392 | $332,022 | 14.71% | 0.08% |
CITIGROUP INC | 02/12/2025 | 35,741 | $293,791 | 5.43% | 0.07% |
FMR LLC | 02/13/2025 | 31,545 | $259,300 | -68.83% | 0.06% |
COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 30,000 | $247,000 | 0.00% | 0.06% |
METLIFE INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 27,785 | $228,393 | 0.00% | 0.06% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 27,623 | $227,061 | 27.34% | 0.06% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 27,512 | $226,149 | -20.08% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 27,341 | $224,743 | 100.00% | 0.06% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 26,568 | $218,389 | 4.48% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 24,300 | $199,746 | -28.11% | 0.05% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 23,820 | $195,800 | 0.00% | 0.05% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 23,058 | $189,537 | -7.02% | 0.05% |
CREATIVE PLANNING | 02/14/2025 | 21,415 | $176,031 | 100.00% | 0.04% |
LETKO, BROSSEAU & ASSOCIATES INC | 02/14/2025 | 21,200 | $174,264 | 0.00% | 0.04% |
Aura Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Aura Biosciences, Inc.. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 6.92 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.88 M
EVENTIDE ASSET MANAGEMENT, LLC: 4.08 M
BlackRock Funding, Inc. /DE: 3.55 M
Medicxi Ventures Management (Jersey) Ltd: 3.04 M
Long Focus Capital Management, LLC: 2.54 M
79.43% of Aura Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 43.10 M shares in the last 24 months. This purchase volume represents approximately $354.27 M in transactions.